Heart Failure is one of the largest causes of death with 1 in 8 deaths attributed to the disease and 75% of people diagnosed with heart failure die within 5 years. The economic cost exceeds US$ 100 billion annually with 10 million deaths each year.
Tragically, most cases of heart failure are not detected until symptoms appear and it is often too late. Our mission is to lower the incidence of fatal heart failure by identifying asymptomatic, high-risk patients early.
Since 2017, ESN Cleer’s ensemble of field leaders has made enormous strides beyond the exceptional science and technology developed. Our prototype is built with clinical validation in progress, we’re entering the next phase towards commercialisation.